SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
February 16 2022 - 7:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven
medicine, today announced it will release its financial
results for the fourth quarter and full year 2021 before U.S.
markets open on Tuesday, March 15, 2022. SOPHiA will host a
conference call and live webcast to discuss its financial results
as well as business outlook beginning at 8:30 a.m. Eastern Time /
2:30 p.m. Central European Time.
The call will be webcast live on the SOPHiA Investor Relations
website. Additionally, an audio replay of the conference call and
webcast will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-based platform
capable of analyzing data and generating insights from complex
multimodal data sets and different diagnostic modalities. The
SOPHiA DDM™ Platform and related solutions, products and services
are currently used by approximately 790 hospital, laboratory, and
biopharma institutions globally. For more information, visit
SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram.
Where others see data, we see answers.
Investor Contact:Jennifer PottageHead of
Investor RelationsJpottage@sophiagenetics.com
Media Contact:Eliza BamontiDirector of Public
RelationsEbamonti@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jul 2023 to Jul 2024